$CHTP Headlines U.S. stocks fall on Fed fears after S&P

New Post Public Reply Private Reply Replies (0) Message Board

Jun 22, 2014 at 11:56 AM

$CHTP Headlines

U.S. stocks fall on Fed fears after S&P 500 nears high 5:49 p.m. Feb. 19, 2014 - Anora Mahmudova
Zale soars on deal; U.S. Steel down on tariff ruling 5:33 p.m. Feb. 19, 2014 - Sue Chang
Kiev in flames, consumer-stock flop, Europe on top and an inflation surprise 9:37 a.m. Feb. 19, 2014 - Barbara Kollmeyer
Chelsea shares jump 35% after hours on hypotension drug approval 8:01 p.m. Feb. 18, 2014 - Russ Britt
Herbalife shares rise on earnings, La-Z-Boy drops 7:22 p.m. Feb. 18, 2014 - Wallace Witkowski
Chelsea Therapeutics shares are halted: Nasdaq 5:17 p.m. Feb. 18, 2014 - Laura Mandaro
Wednesday’s movers: Herbalife slumps after call 5:57 p.m. Feb. 20, 2013 - Sue Chang
Chelsea Therapeutics CEO, other execs step down 7:17 a.m. July 10, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 1:00 p.m. May 31, 2012 - MarketWatch
Chelsea shares tumble on FDA setback 10:53 a.m. March 29, 2012 - MarketWatch.com
FDA seeks more info from Chelsea Therapeutics 8:22 a.m. March 29, 2012 - Greg Morcroft
Chelsea Therapeutics falls 23% in premarket 8:04 a.m. March 29, 2012 - Steve Gelsi
FDA decision nears for Chelsea Therapeutics 12:10 p.m. March 14, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 5:40 p.m. Feb. 24, 2012 - Kate Gibson
Chelsea Therapeutics soars on FDA nod 2:13 p.m. Feb. 24, 2012 - Val Brickates Kennedy
Chelsea Therapeutics up 71% in premarket 8:58 a.m. Feb. 24, 2012 - Steve Gelsi
Stocks to watch Friday: Deckers, Salesforce, Crocs 7:49 a.m. Feb. 24, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 5:51 p.m. Feb. 13, 2012 - MarketWatch
Chelsea plunges 36% ahead of FDA update 11:54 a.m. Feb. 13, 2012 - Val Brickates Kennedy
Chelsea Therapeutics jumps 8% on ADHD study 12:15 p.m. July 26, 2011 - Val Brickates Kennedy

Lundbeck Delivers Some Data-Driven Upside 7:00 a.m. June 20, 2014 - Seeking Alpha
Waiting period over for Chelsea-Lundbeck transaction 7:37 a.m. June 6, 2014 - Seeking Alpha
Chelsea Therapeutics Deal Terms: Be Careful 12:18 p.m. June 2, 2014 - Seeking Alpha
Chelsea Therapeutics - Going Private Transaction Provides Significant Upside 9:00 a.m. May 29, 2014 - Seeking Alpha
Lundbeck Starting Slow, But Still Looking For The Big Finish 11:35 a.m. May 9, 2014 - Seeking Alpha
Lundbeck to Buy Chelsea Therapeutics for $658M 11:31 a.m. May 8, 2014 - TheStreet.com
Why Chelsea Therapeutics (CHTP) Stock Is Soaring Today 10:05 a.m. May 8, 2014 - TheStreet.com
Chelsea Exits in Victory With Lundbeck Takeout 9:05 a.m. May 8, 2014 - TheStreet.com
More on Chelsea-Lundbeck deal: Lundbeck gains rights to Northera 8:36 a.m. May 8, 2014 - Seeking Alpha
Chelsea Therapeutics International Enters Oversold Territory (CHTP) 12:27 p.m. April 15, 2014 - TheStreet.com
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook 2:17 a.m. March 26, 2014 - Zacks.com
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews 2:17 a.m. March 26, 2014 - Zacks.com
OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals 1:35 p.m. March 25, 2014 - Seeking Alpha
Chelsea Therapeutics Posts Wider Q4 Loss - Analyst Blog 1:41 p.m. March 12, 2014 - Zacks.com
10-K: CHELSEA THERAPEUTICS INTERNATIONAL, LTD. 4:22 p.m. March 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Chelsea Therapeutics: Caution Warranted 9:49 a.m. Feb. 25, 2014 - Seeking Alpha
Company news for February 20, 2014 - Corporate Summary 11:06 a.m. Feb. 20, 2014 - Zacks.com
CHTP's Northera Gains FDA Approval - Analyst Blog 7:20 p.m. Feb. 19, 2014 - Zacks.com
Chelsea Moving on to the Revenue Stage of Its Cycle 11:00 a.m. Feb. 19, 2014 - 247WallSt.com
Analysts add to Chelsea feel-good factor 10:38 a.m. Feb. 19, 2014 - Seeking Alpha

NORTHERA(TM) Clinical Trial Data Published in Neurology 4:30 p.m. June 19, 2014 - GlobeNewswire
Upcoming Conferences, Tentative Meeting Schedules, Analyst Day, Public Offerings, and Data Presentations - Analyst Notes on Incyte, NPS Pharmaceuticals, Arrowhead, Novavax and Chelsea Therapeutics 5:00 a.m. June 17, 2014 - PR Newswire - PRF
Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders 7:29 a.m. June 12, 2014 - GlobeNewswire
Chelsea Therapeutics Announces the Expiration of the Hart-Scott-Rodino Waiting Period in Relation to the Proposed Acquisition of Chelsea Therapeutics by Lundbeck 7:00 a.m. June 6, 2014 - GlobeNewswire
The Law Office of Robbins Arroyo LLP Announces Class Action Lawsuit Against Chelsea Therapeutics International, Ltd. 3:32 p.m. June 2, 2014 - PR Newswire - PRF
Active Stocks Technical Coverage -- Research on Callaway Golf, Annaly Capital Management, Weatherford Intl., and Chelsea Therapeutics Intl. 11:11 a.m. May 21, 2014 - PR Newswire - PRF
Chelsea Therapeutics Shareholder Alert:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate the Acquisition Proposal from H. Lundbeck A/S 10:58 a.m. May 21, 2014 - BusinessWire - BZX
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene 7:20 a.m. May 13, 2014 - PR Newswire - PRF
Acquisition Chelsea Therapeutics International, Ltd by H. Lundbeck A/S May Not Be in Shareholders' Best Interests 11:44 a.m. May 12, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Chelsea Therapeutics International, Ltd. 9:15 p.m. May 9, 2014 - BusinessWire - BZX
Harwood Feffer LLP Announces Investigation of Chelsea Therapeutics International, Ltd. 8:40 p.m. May 9, 2014 - PR Newswire - PRF
Lifshitz & Miller Law Firm Announces Investigation of Chelsea Therapeutics International Ltd., KBR, Inc., OmniAmerican Bancorp, Inc., PokerTek, Inc., SP Bancorp, Inc. and 1st United Bancorp, Inc. 7:51 p.m. May 9, 2014 - PR Newswire - PRF
Ryan & Maniskas, LLP Announces Investigation of Chelsea Therapeutics International Ltd. 10:35 a.m. May 9, 2014 - PR Newswire - PRF
Newman Ferrara LLP Announces Investigation of Chelsea Therapeutics International Ltd. 10:09 a.m. May 9, 2014 - BusinessWire - BZX
Law Offices of Marc S. Henzel Announces Securities Class Action Periods 9:11 a.m. May 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Chelsea Therapeutics International, Ltd. in Connection with the Proposed Sale of the Company to H. Lundbeck A/S 9:00 p.m. May 8, 2014 - BusinessWire - BZX
CHELSEA THERAPEUTICS ALERT: Johnson & Weaver Investigating the Proposed Sale of Chelsea Therapeutics International, Ltd. 8:45 p.m. May 8, 2014 - BusinessWire - BZX
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders 6:35 p.m. May 8, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Office of James C. Kelly Investigates Claims That the Proposed Acquisition of Chelsea Therapeutics International, Ltd. May Not Be in its Investors' Best Interests 5:25 p.m. May 8, 2014 - PR Newswire - PRF
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 1:22 p.m. May 8, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...